NCT02113904View on ClinicalTrials.gov

Clinical Trial Using Humira in Netherton Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 27, 2014

Primary Completion Date

December 20, 2016

Study Completion Date

September 21, 2017

Conditions
Netherton Syndrome
Interventions
DRUG

Adalimumab

6 injections (one every 15 days during 3 months)

Trial Locations (1)

75015

Necker Enfants Malades hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02113904 - Clinical Trial Using Humira in Netherton Syndrome | Biotech Hunter | Biotech Hunter